Driving Discovery: 600+ Studies Featuring Our Products

Advancing scientific discovery with validated research tools

For researchers in immunology, inflammation, and rare disease research, choosing the best immunoassays and cell-based assays is critical for generating reliable, high-impact data. Our assays have been now featured in 600+ peer-reviewed scientific publications, demonstrating their role in biomarker discovery, clinical research, and drug development.

With this latest 2024 update to our publication list, you can now explore studies showcasing how our assays support groundbreaking discoveries, from basic research to approved therapies.

In 2024 alone, 38 new publications utilized our complement system assay products, reflecting the growing impact of high-sensitivity immunoassays in translational and clinical research.

Clinical Research is about impact
– not volume

We are proud to support researchers in generating high-quality, reproducible data that advances scientific understanding and brings new therapies to patients.

It takes 10–15 years for a new therapeutic to go from discovery to submission for approval.

Every study in these publications represents critical steps in that journey, supporting:

• Detection of complement system activation in autoimmune and inflammatory diseases
• Evaluation of drug response and immune modulation in clinical trials
• Identification of predictive biomarkers for patient stratification
• Supporting regulatory submissions for complement-targeted therapies

Find reliable complement immunoassays and robust cell-based assays for your research

Explore our comprehensive publication database.
Our updated resource allows you to:

• Find studies using our assays, categorized by product 
• PubMed links directly
• Stay informed about the latest applications of complement therapeutics, immunoassays and cell-based assays